Key result
Surgical cryoablation guided by preoperative mapping reduced the number of implantable cardioverter-defibrillator shocks from 6.6 to 0.6 per patient.
Why the study?
Does surgical cryoablation guided by preoperative mapping reduce VT burden in patients with nonischemic cardiomyopathy and refractory VT inaccessible to percutaneous ablation?
Observational (n=8)
Does surgical cryoablation guided by preoperative mapping reduce VT burden in patients with nonischemic cardiomyopathy and refractory VT inaccessible to percutaneous ablation?
Surgical cryoablation guided by preoperative mapping is a viable and effective alternative for reducing VT burden in patients with nonischemic cardiomyopathy whose VT circuits are inaccessible to percutaneous ablation.
Answers are grounded in this paper and cite their sources.
May offer option for refractory VT inaccessible percutaneously in nonischemic cardiomyopathy; hypothesis-generating, requires prospective validation before practice change.
BACKGROUND: The surgical approach for the treatment of ventricular tachycardia (VT) has been largely replaced by percutaneous, catheter-based techniques. However, some VT circuits, particularly in patients with nonischemic cardiomyopathy, remain inaccessible to percutaneous ablation. Surgical therapy of these VTs is an alternative approach; however, its methodology has not been well defined. The purpose of this study was to evaluate the efficacy of preoperative electroanatomic and electrophysiological characterization of the VT substrate and circuit to guide surgical ablation. METHODS AND RESULTS: Eight patients with recurrent sustained VT refractory to antiarrhythmic drugs underwent endocardial and/or epicardial ablation procedures. Electroanatomic mapping was performed, and the VT substrate and circuit(s) were defined using voltage, activation, entrainment, and pace mapping. All 8 patients underwent detailed endocardial mapping; 6 patients also underwent epicardial mapping. Radiofrequency ablation was performed with the use of an open-irrigation catheter. After the unsuccessful percutaneous approach, surgical cryoablation was applied to the sites previously identified and targeted during the percutaneous procedure. There were no significant perioperative complications. During a mean follow-up period of 23 ± 6 months (range, 15 to 34 months), 6 patients had significant reduction in VT burden as evident by a reduced number of implantable cardioverter-defibrillator shocks after ablation (6.6 to 0.6 shocks per patient; P = 0.026). Two patients died, one of progressive heart failure and one of sepsis. CONCLUSIONS: VT circuits inaccessible to percutaneous ablation techniques are rare but can be encountered in patients with nonischemic cardiomyopathy. These VTs can be successfully targeted by surgical cryoablation guided by preoperative electroanatomic and electrophysiological mapping.
No takes yet. Share an insight, caveat, or question.
Anter et al. (2011) conducted an observational in Refractory ventricular tachycardia in nonischemic cardiomyopathy (n=8). Surgical cryoablation guided by preoperative mapping vs. Pre-ablation (baseline) was evaluated on Number of implantable cardioverter-defibrillator shocks (p=0.026). Surgical cryoablation guided by preoperative mapping reduced the number of implantable cardioverter-defibrillator shocks from 6.6 to 0.6 per patient.
Synapse has enriched 10 related papers. Consider them for comparative context: